Abstract
Objective:
To evaluate the clinical efficacy of three-dimensional visualization reconstruction (3DVR) in surgical planning for complex retroperitoneal liposarcoma (RLS), we report a case of a 64-year-old female patient presenting with a mass posterior to the spleen. CT/MRI revealed a retro-splenic mass, later pathologically confirmed as dedifferentiated liposarcoma. 3D reconstruction precisely delineated a 12 × 6.0 cm tumor with three splenic feeding vessels, enabling preoperative simulation of an en bloc resection combined with splenectomy. Gross total resection (R0 resection) was achieved, and pathology confirmed no splenic invasion. No recurrence was observed during 6-month follow-up.
Conclusion:
Compared to 2D imaging, 3D reconstruction improved stereoscopic assessment of tumor-vessel-organ relationships, reducing intraoperative uncertainty. Challenges in retroperitoneal soft-tissue contrast were mitigated using advanced segmentation. The technique enhances surgical precision, lowers operative risks, and may improve recurrence-free survival. Integration with virtual reality could further optimize preoperative planning, advocating its adoption in complex abdominal oncology.
Introduction
Retroperitoneal liposarcoma (RLS), a rare but aggressive mesenchymal tumor, poses significant therapeutic challenges due to its anatomical complexity, late clinical presentation, and propensity for local recurrence () Complete macroscopic resection remains the cornerstone of curative intent, yet achieving negative margins (R0) is often hindered by the tumor's intricate relationships with retroperitoneal vasculature and viscera (). Conventional imaging modalities, such as two-dimensional (2D) computed tomography (CT), provide limited spatial resolution for preoperative planning, particularly in cases of distorted anatomy or multifocal vascular involvement ().
Case presentation
A 64-year-old female patient was admitted with a 5-month history of intermittent abdominal discomfort. Physical examination revealed mild abdominal distension with slight tenderness in the left upper quadrant, without rebound tenderness or muscle rigidity. No palpable mass was detected. Contrast-enhanced abdominal CT (Figures 1a,b) demonstrated a suspicious malignant lesion lateral to the spleen, possibly of splenic origin. Abdominal MRI (Figure 2) revealed: (1) a retro-splenic mass suggestive of liposarcoma; (2) hemoperitoneum. The clinical diagnosis was retroperitoneal liposarcoma. Preoperative Three-Dimensional Reconstruction Preoperative three-dimensional reconstruction (Figures 3A–E) localized the tumor dorsal to the spleen, showing three vascular branches originating from the spleen feeding the tumor. Clear boundaries were observed between the tumor and adjacent structures (kidney, renal artery, pancreas, and bowel), with significant peritumoral fluid accumulation.
Figure 1
Figure 2
Figure 3
Surgical Intervention Exploratory laparotomy identified a 12 cm × 6.0 cm × 5 cm encapsulated mass (Figure 4) in the left retro-splenic region. The mass exhibited dense adhesions to the spleen, with partial blood supply derived from splenic vessels. The total operative time was 185 min. Estimated intraoperative blood loss was 450 ml, requiring no blood transfusion. Due to challenging dissection and significant intraoperative bleeding from tumor-splenic adhesions, en bloc resection of the tumor with splenectomy was performed. The patient was transferred to the general ward postoperatively without ICU admission.
Figure 4
Pathological and Immunohistochemical Findings Histopathological examination (Figure 5) revealed predominantly spindled to polygonal cells exhibiting enlarged hyperchromatic nuclei with prominent nucleoli and readily identified mitotic figures. The neoplastic cells displayed disorganized architectural patterns, including fascicular, storiform, or diffuse arrangements, within a stromal background demonstrating variable myxoid change, hyalinization, or collagenization. Immunohistochemistry showed: Cyclin-dependent kinase 4 (CDK4) (+)、Mouse double minute 2 homolog (MDM2) (+)、Ki-67 (10%+)、CD34 (vascular+)、ERG (vascular+)、CK (-)、EpCAM (-)、CD68 (focal+)、Calretinin (-)、p16 (focal+).
Figure 5
Postoperative Follow-up The patient resumed oral intake on postoperative day 2 and was discharged on day 7 without complications (Clavien-Dindo grade 0). At the 6-month surveillance (contrast-enhanced CT), no recurrence was observed.
Discussion
The management of retroperitoneal liposarcoma (RLS) hinges on achieving complete macroscopic resection, as incomplete tumor removal remains the primary driver of postoperative recurrence (, ). This challenge is compounded by the tumor's insidious growth within anatomically complex retroperitoneal spaces, where lesions often exceed 20 cm at diagnosis, distorting normal anatomy and obscuring critical vascular landmarks (). While contrast-enhanced CT provides foundational diagnostic insights (), its inherent 2D limitations—poor spatial resolution of tumor-vessel interfaces and inadequate soft-tissue contrast—frequently undermine preoperative risk stratification ().
This case exemplifies how 3D visualization reconstruction addresses these limitations. By converting 2D CT datasets into interactive stereoscopic models, surgeons gain un-paralleled spatial perception of tumor morphology, vascular supply (e.g., three splenic feeding vessels in this case), and anatomical relationships (). Dynamic manipulation of these models—rotation, magnification, and virtual tissue dissection—enables pre-operative simulation of resection margins and contingency planning for vascular control (, ). Such capabilities proved pivotal in our patient, where 3D guidance facilitated en bloc resection of a 12 cm splenic-adherent mass while minimizing intraoperative exploration and hemorrhage. Our estimated blood loss (EBL) of 450 ml was significantly lower than that reported for typical RLS cohorts (600–1,200 ml) (, ). This reduced EBL is attributable to preoperative 3D planning, which identified splenic feeding vessels and enabled proactive vascular control. Operative time (185 min) was within the lower range of published data (, ), likely due to minimized intraoperative exploration. The absence of transfusions or complications contrasts sharply with the higher rates reported in the literature (, , ), supporting 3DVR's role in mitigating surgical morbidity. The gross specimen of the postoperative tumor (Figure 4) demonstrated well-defined borders, consistent with the 3D computational model predictions.
Notably, 3D technology's adoption in retroperitoneal oncology lags behind its success in solid organ surgery [e.g., hepatic/pancreatic resections ()]. This disparity stems from technical barriers: retroperitoneal fat's homogeneous density on CT complicates tumor segmentation, while multifocal vascular encasement demands advanced algorithms to differentiate tumor margins from displaced structures (). However, emerging solutions—such as dual-energy CT for enhanced soft-tissue contrast and AI-driven edge detection—are bridging these gaps, promising higher-fidelity 3D models ().
Current evidence () confirms that complete surgical resection remains the cornerstone therapeutic intervention for retroperitoneal liposarcoma, demonstrating significant reduction in local recurrence rates compared to incomplete excision. The integration of three-dimensional visualization reconstruction technology enables precise intraoperative tumor demarcation, which critically facilitates R0 resection achievement and is associated with statistically significant reduction in locoregional recurrence rates. The high recurrence rates of RLS [40%–60% within 5 years ()] further underscore the need for precision tools. Although the current 6-month follow-up interval remains limited in duration for recurrence assessment, the patient will be enrolled in a structured surveillance protocol comprising annual contrast-enhanced MRI (per NCCN Guidelines Version 3.2023) over a minimum 5-year continuum, with protocol-defined interim analyses to be reported at standardized 24-month intervals using RECIST 1.1 criteria. Reoperative resection, though fraught with complications, remains the sole curative option for recurrent disease. Here, 3D reconstruction's value extends beyond initial surgery: in reoperative fields with scarred anatomy, it provides a virtual roadmap to distinguish tumor pseudocapsules from adhesions, potentially reducing iatrogenic injuries ().
Future Directions: Integrating 3D models with virtual reality (VR) platforms could enable immersive preoperative rehearsals, while machine learning may predict tumor biology to optimize resection margins. For now, this case validates 3D reconstruction as a transformative adjunct in RLS management, advocating its routine integration into multidisciplinary workflows to mitigate surgical morbidity and improve oncologic outcomes.
Conclusions
3D reconstruction technology significantly enhances retroperitoneal tumor management by enabling precise anatomical mapping and complete resection, thereby reducing recurrence risks. Future integration with virtual reality (VR) will allow immersive surgical simulation, optimizing strategies for complex anatomy. Broader adoption of 3D-guided workflows promises to redefine standards of care, improving survival outcomes in retroperitoneal malignancies. While our technique achieved R0 resection in this cohort—a known predictor of reduced recurrence—longer follow-up is needed to assess its survival impact.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by Affiliated Hospital of Hebei University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
XR: Supervision, Writing – original draft, Writing – review & editing. TX: Formal analysis, Writing – review & editing. LL: Methodology, Writing – review & editing. XJ: Conceptualization, Investigation, Writing – review & editing. MZ: Data curation, Investigation, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by Youth Research Fund of Affiliated Hospital of Hebei University, grant number 2021Q024.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
StraussDCHayesAJThwayKMoskovicECFisherCThomasJM. Surgical management of primary retroperitoneal sarcoma. Br J Surg. (2010) 97(5):698–706. 10.1002/bjs.6994
2.
Marjiyeh-AwwadRMansourSKhuriS. Giant retroperitoneal liposarcoma: correlation between size and risk for recurrence. World J Oncol. (2022) 13(5):244–8. 10.14740/wjon1528
3.
LeeSYGohBKTeoMCChewMHChowPKWongWKet alRetroperitoneal liposarcomas: the experience of a tertiary Asian center. World J Surg Oncol. (2011) 9:12. 10.1186/1477-7819-9-12
4.
FangCHLiuJFanYFYangJXiangNZengN. Outcomes of hepatectomy for hepatolithiasis based on 3-dimensional reconstruction technique. J Am Coll Surg. (2013) 217:280–8. 10.1016/j.jamcollsurg.2013.03.017
5.
LilesJSTzengC-WDShortJJKuleszaPHeslinMJ. Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg. (2009) 46(6):445–503. 10.1067/j.cpsurg.2009.01.004
6.
ZeinNNHanounehABishopPDSamaanMEghtesadBQuintiniCet alThree-dimensional print of a liver for preoperative planning in living donor liver transplantation. Liver Transpl. (2013) 19:1304–10. 10.1002/lt.23729
7.
TakahashiKSasakiRKondoTOdaTMurataSOhkohchiN. Preoperative 3D volumetric analysis for liver congestion applied in a patient with hilar cholangiocarcinoma. Langenbecks Arch Surg. (2010) 395:761–5. 10.1007/s00423-009-0572-y
8.
ErzenDSencarMNovakJ. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the institute of oncology, Ljubljana. J Surg Oncol. (2005) 91(1):1–9. 10.1002/jso.20265
9.
GuoQChenJPuTZhaoYXieKGengXet alThe value of three-dimensional visualization techniques in hepatectomy for complicated hepatolithiasis: a propensity score matching study. Asian J Surg. (2023) 46(2):767–73. 10.1016/j.asjsur.2022.07.005
10.
FlemingRWHoltmann-RiceDBulthoffHH. Estimation of 3D shape from image orientation. Proc Natl Acad Sci. (2011) 108:20438–43. 10.1073/pnas.1114619109
11.
GaoXDingPZhangZLiYZhaoQWangDet alAnalysis of recurrence and metastasis patterns and prognosis after complete resection of retroperitoneal liposarcoma. Front Oncol. (2023) 13:1273169. 10.3389/fonc.2023.1273169
12.
MarconiSPuglieseLBottiMPeriACavazziELatteriSet alValue of 3D printing for the comprehension of surgical anatomy. Surg Endosc. (2017) 31(10):4102–10. 10.1007/s00464-017-5457-5
Summary
Keywords
three-dimensional visualization reconstruction, retroperitoneal liposarcoma, surgical precision, preoperative planning, case report
Citation
Ren X, Xie T, Liu L, Jin X and Zhang M (2025) Three-Dimensional visualization reconstruction assisted in the treatment of retroperitoneal liposarcoma: a case report. Front. Surg. 12:1609274. doi: 10.3389/fsurg.2025.1609274
Received
10 April 2025
Accepted
02 July 2025
Published
16 July 2025
Volume
12 - 2025
Edited by
Terence Moyana, The Ottawa Hospital, Canada
Reviewed by
Gionata Spagnoletti, Bambino Gesù Children's Hospital (IRCCS), Italy
Zhuang Aobo, Xiamen University, China
Updates
Copyright
© 2025 Ren, Xie, Liu, Jin and Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Meng Zhang pfkzm1991@163.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.